Hyderabad, May 5: Kuehne+Nagel has expanded its healthcare logistics footprint in India with the opening of a new temperature-controlled airfreight cross dock facility in Hyderabad. The investment strengthens the company’s ability to support the safe, compliant and reliable movement of healthcare products, in response to growing demand for specialised logistics solutions for pharmaceutical and medical shipments.
Hyderabad is a major centre for pharmaceutical manufacturing, contributing over 40 per cent of India’s active pharma ingredients and vaccine production. Strategically located within this ecosystem, Kuehne+Nagel’s new facility supports efficient handling and distribution while improving proximity to key customers and manufacturing sites.
The 248 sqm facility operates across dedicated temperature zones, including +2°C to +8°C and +15°C to +25°C. These controlled environments are designed to safeguard product integrity across a wide range of healthcare shipments. The site complies with Kuehne+Nagel’s global HealthChain quality standard, ensuring consistent GxP compliance across healthcare supply chains. With the addition of Hyderabad, Kuehne+Nagel now operates two HealthChain-certified facilities in India, following the launch of its Bengaluru Cool Zone facility in December 2025.
Anish Kumar Jha, Managing Director for Kuehne+Nagel India, Sri Lanka and the Maldives, said:
“This investment strengthens our healthcare logistics network in India and brings us closer to customers operating in one of the country’s most important pharmaceutical hubs. By investing in specialised, HealthChain-certified infrastructure, we are supporting Indian healthcare companies as they grow and connect to global markets through compliant, temperature-controlled supply chains.”
